Skip to Content

Erythrocin Lactobionate

In the US, Erythrocin Lactobionate (erythromycin systemic) is a member of the drug class macrolides and is used to treat Bacterial Endocarditis Prevention, Bartonellosis, Bowel Preparation, Bronchitis, Bullous Pemphigoid, Campylobacter Gastroenteritis, Chancroid, Chlamydia Infection, Dental Abscess, Legionella Pneumonia, Lyme Disease, Lymphogranuloma Venereum, Mycoplasma Pneumonia, Nongonococcal Urethritis, Ocular Rosacea, Otitis Media, Pemphigoid, Pertussis, Pharyngitis, Pneumonia, Rheumatic Fever Prophylaxis, Skin or Soft Tissue Infection, Strep Throat, Syphilis - Early and Upper Respiratory Tract Infection.

US matches:

Ingredient matches for Erythrocin Lactobionate

Erythromycin

Erythromycin is reported as an ingredient of Erythrocin Lactobionate in the following countries:

  • Israel

Erythromycin lactobionate (a derivative of Erythromycin) is reported as an ingredient of Erythrocin Lactobionate in the following countries:

  • Malta
  • Taiwan
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide